Apyx Medical Expects FY2024 Sales Of $49.7M-$52.9M Versus Consensus Of $60.18M, With Net Loss Of $(26.5)M-$(24.3)M
Apyx Medical Expects FY2024 Sales Of $49.7M-$52.9M Versus Consensus Of $60.18M, With Net Loss Of $(26.5)M-$(24.3)M
Apyx Medical 預計 FY2024 的銷售額爲4,970萬至5,290萬美元，而市場預期爲6,018萬美元，淨虧損爲2650萬美元（2430萬美元）
- Total revenue guidance assumes:
- Advanced Energy revenue in the range of $41.6 million to $44.6 million, representing a decrease of approximately 4% to growth of approximately 3% year-over-year, compared to Advanced Energy revenue of $43.4 million for the year ended December 31, 2023.
- OEM revenue in the range of $8.1 million to $8.3 million, representing a decrease of 10% to 7% year-over-year, compared to $9.0 million for the year ended December 31, 2023.
- 總收入指導假設：
- 先進能源收入在4,160萬美元至4,460萬美元之間，同比下降約4％，同比增長約3％，而截至2023年12月31日的年度先進能源收入爲4,340萬美元。
- 原始設備製造商收入在810萬美元至830萬美元之間，與截至2023年12月31日止年度的900萬美元相比，同比下降10％至7％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。